- Home
- BMEA vs LPA Comparison
BMEA vs LPA Comparison
Compare BMEA & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- LPA
- Stock Information
- Founded
- BMEA 2017
- LPA 2013
- Country
- BMEA United States
- LPA United States
- Employees
- BMEA N/A
- LPA N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- LPA
- Sector
- BMEA Health Care
- LPA
- Exchange
- BMEA Nasdaq
- LPA Nasdaq
- Market Cap
- BMEA 275.6M
- LPA 321.2M
- IPO Year
- BMEA 2021
- LPA N/A
- Fundamental
- Price
- BMEA $11.24
- LPA $8.10
- Analyst Decision
- BMEA Buy
- LPA
- Analyst Count
- BMEA 13
- LPA 0
- Target Price
- BMEA $36.33
- LPA N/A
- AVG Volume (30 Days)
- BMEA 1.1M
- LPA 29.6K
- Earning Date
- BMEA 11-01-2024
- LPA 01-01-0001
- Dividend Yield
- BMEA N/A
- LPA N/A
- EPS Growth
- BMEA N/A
- LPA N/A
- EPS
- BMEA N/A
- LPA N/A
- Revenue
- BMEA N/A
- LPA $41,666,983.00
- Revenue This Year
- BMEA N/A
- LPA N/A
- Revenue Next Year
- BMEA N/A
- LPA N/A
- P/E Ratio
- BMEA N/A
- LPA N/A
- Revenue Growth
- BMEA N/A
- LPA 16.37
- 52 Week Low
- BMEA $3.61
- LPA $6.00
- 52 Week High
- BMEA $22.74
- LPA $525.00
- Technical
- Relative Strength Index (RSI)
- BMEA 64.18
- LPA N/A
- Support Level
- BMEA $10.35
- LPA N/A
- Resistance Level
- BMEA $12.30
- LPA N/A
- Average True Range (ATR)
- BMEA 0.93
- LPA 0.00
- MACD
- BMEA -0.01
- LPA 0.00
- Stochastic Oscillator
- BMEA 47.26
- LPA 0.00
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About LPA Logistic Properties of the Americas
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns and manages a diversified portfolio of warehouse logistics assets in Central America and the South America. It focuses on modern Class A logistics real estate in high growth and high barrier-to-entry markets that are undersupplied and have low penetration rates.